To ensure safety of all of Dar Al Dawa’s medicines, we hold and maintain an active pharmacovigilance program. Our commitment to pharmacovigilance aims, to focus on the safety and well-being  of our patients which has always been and shall remain our utmost priority.

Pharmacovigilance activities include the detection, assessment, understanding and prevention of adverse effects or any other drug related problems.

In order to ensure fulfillment of our pharmacovigilance activities, please report any adverse drug reactions or drug related problem related to any of Dar Al Dawa products.

What should I report ?

• Adverse Drug reactions
• Lack of efficacy
• Overdose, abuse, misuse, off-label use
• Use of drug during pregnancy and breastfeeding
• Quality defects, or counterfeits
• Medication errors
• Drug interactions
• Occupational exposure